文献

J-GLOBAL ID：202202247638635950   整理番号：22A1150018

広域スペクトルβ-ラクタマーゼ産生Escherichia coliによる尿由来の菌血症患者における経口抗生物質移行

Oral Antibiotic Transition in Patients with Bacteremia with a Urinary Source Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli

著者 (11件)： Noguchi Taro (Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan) ,  Shinohara Koh (Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan) ,  Tsuchido Yasuhiro (Department of Infection Control and Clinical Laboratory, Kyoto Prefectural University of Medicine, Japan) ,  Yukawa Satomi (Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan) ,  Yamamoto Masaki (Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan) ,  Matsumura Yasufumi (Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan) ,  Hayashi Michiko (Department of Clinical Laboratory, Kyoto Miniren Chuo Hospital, Japan) ,  Yamada Yutaka (Department of Infectious Diseases, Kyoto Miniren Chuo Hospital, Japan) ,  Hayashi Akihiko (Department of Clinical Laboratory, Kyoto City Hospital, Japan) ,  Shimizu Tsunehiro (Department of Infectious Diseases, Kyoto City Hospital, Japan) ,  Nagao Miki (Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan)
資料名： Japanese Journal of Infectious Diseases  (Japanese Journal of Infectious Diseases)
巻： 75  号： 2  ページ： 205-208(J-STAGE)  発行年： 2022年 
JST資料番号： F0552A  ISSN： 1344-6304  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： Escherichia coli菌血症に対する静脈内から経口...

シソーラス用語： ヒト ,...
準シソーラス用語： ESBL ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1150018&from=J-GLOBAL&jstjournalNo=F0552A") }}

著者キーワード (4件)： 拡張スペクトルβ-ラクタマーゼ ,  大腸菌 ,  菌血症 ,  口腔スイッチ

分類 (2件)： 感染症・寄生虫症一般  (GD01010H) ,  病原体に作用する抗生物質の臨床への応用  (GX05030N)

引用文献 (12件)：

• 1. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 25th informational supplement. Document M100-S25. Wayne, PA: CLSI; 2015.
• 2. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
• 3. Akhloufi H, Hulscher M, Melles DC, et al. Development of operationalized intravenous to oral antibiotic switch criteria. J Antimicrob Chemother. 2017;72:543-546.
• 4. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791-797.
• 5. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.

タイトルに関連する用語 (9件)： 広域 ,  スペクトル ,  β-ラクタマーゼ ,  Escherichia ,  尿 ,  菌血症 ,  患者 ,  抗生物質 ,  移行